The impact of transcription on metabolism in prostate and breast cancers

Metabolic dysregulation is regarded as an important driver in cancer development and progression. The impact of transcriptional changes on metabolism has been intensively studied in hormone-dependent cancers, and in particular, in prostate and breast cancer. These cancers have strong similarities in...

Full description

Bibliographic Details
Main Authors: Poulose, N, Mills, I, Steele, R
Format: Journal article
Language:English
Published: Bioscientifica 2018
_version_ 1797054653847830528
author Poulose, N
Mills, I
Steele, R
author_facet Poulose, N
Mills, I
Steele, R
author_sort Poulose, N
collection OXFORD
description Metabolic dysregulation is regarded as an important driver in cancer development and progression. The impact of transcriptional changes on metabolism has been intensively studied in hormone-dependent cancers, and in particular, in prostate and breast cancer. These cancers have strong similarities in the function of important transcriptional drivers, such as the oestrogen and androgen receptors, at the level of dietary risk and epidemiology, genetics and therapeutically. In this review, we will focus on the function of these nuclear hormone receptors and their downstream impact on metabolism, with a particular focus on lipid metabolism. We go on to discuss how lipid metabolism remains dysregulated as the cancers progress. We conclude by discussing the opportunities that this presents for drug repurposing, imaging and the development and testing of new therapeutics and treatment combinations.
first_indexed 2024-03-06T19:00:15Z
format Journal article
id oxford-uuid:1346c44e-ec65-4b27-89ab-84b436306c31
institution University of Oxford
language English
last_indexed 2024-03-06T19:00:15Z
publishDate 2018
publisher Bioscientifica
record_format dspace
spelling oxford-uuid:1346c44e-ec65-4b27-89ab-84b436306c312022-03-26T10:12:59ZThe impact of transcription on metabolism in prostate and breast cancersJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1346c44e-ec65-4b27-89ab-84b436306c31EnglishSymplectic Elements at OxfordBioscientifica2018Poulose, NMills, ISteele, RMetabolic dysregulation is regarded as an important driver in cancer development and progression. The impact of transcriptional changes on metabolism has been intensively studied in hormone-dependent cancers, and in particular, in prostate and breast cancer. These cancers have strong similarities in the function of important transcriptional drivers, such as the oestrogen and androgen receptors, at the level of dietary risk and epidemiology, genetics and therapeutically. In this review, we will focus on the function of these nuclear hormone receptors and their downstream impact on metabolism, with a particular focus on lipid metabolism. We go on to discuss how lipid metabolism remains dysregulated as the cancers progress. We conclude by discussing the opportunities that this presents for drug repurposing, imaging and the development and testing of new therapeutics and treatment combinations.
spellingShingle Poulose, N
Mills, I
Steele, R
The impact of transcription on metabolism in prostate and breast cancers
title The impact of transcription on metabolism in prostate and breast cancers
title_full The impact of transcription on metabolism in prostate and breast cancers
title_fullStr The impact of transcription on metabolism in prostate and breast cancers
title_full_unstemmed The impact of transcription on metabolism in prostate and breast cancers
title_short The impact of transcription on metabolism in prostate and breast cancers
title_sort impact of transcription on metabolism in prostate and breast cancers
work_keys_str_mv AT poulosen theimpactoftranscriptiononmetabolisminprostateandbreastcancers
AT millsi theimpactoftranscriptiononmetabolisminprostateandbreastcancers
AT steeler theimpactoftranscriptiononmetabolisminprostateandbreastcancers
AT poulosen impactoftranscriptiononmetabolisminprostateandbreastcancers
AT millsi impactoftranscriptiononmetabolisminprostateandbreastcancers
AT steeler impactoftranscriptiononmetabolisminprostateandbreastcancers